Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction

Retrovirology. 2005 Apr 4:2:23. doi: 10.1186/1742-4690-2-23.

Abstract

Background: Cellular infection with human immunodeficiency virus (HIV) both in vitro and in vivo requires a member of the chemokine receptor family to act as a co-receptor for viral entry. However, it is presently unclear to what extent the interaction of HIV proteins with chemokine receptors generates intracellular signals that are important for productive infection.

Results: In this study we have used a recently described family of chemokine inhibitors, termed BSCIs, which specifically block chemokine-induced chemotaxis without affecting chemokine ligands binding to their receptors. The BSCI termed Peptide 3 strongly inhibited CCR5 mediated HIV infection of THP-1 cells (83 +/- 7% inhibition assayed by immunofluoresence staining), but had no effect on gp120 binding to CCR5. Peptide 3 did not affect CXCR4-dependent infection of Jurkat T cells.

Conclusion: These observations suggest that, in some cases, intracellular signals generated by the chemokine coreceptor may be required for a productive HIV infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Chemokines / pharmacology*
  • Chemotaxis
  • HIV Envelope Protein gp120 / metabolism*
  • HIV-1 / drug effects*
  • HIV-1 / pathogenicity*
  • Humans
  • Jurkat Cells
  • Macrophages / virology
  • Peptides / chemical synthesis
  • Peptides / pharmacology
  • Receptors, CCR5 / metabolism*
  • Receptors, HIV / metabolism
  • Signal Transduction / drug effects*

Substances

  • Chemokines
  • HIV Envelope Protein gp120
  • Peptides
  • Receptors, CCR5
  • Receptors, HIV